Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

Novartis secures first-line FDA approval in breast cancer indication

March 14, 2017
Manufacturing and Production, Sales and Marketing Kisqali, Novartis, breast cancer

The FDA has approved Kisqali (ribociclib) in combination with letrozole for the first-line treatment of postmenopausal women with hormone receptor …

News
novartis_headquarters

South Korea fines Novartis over kickbacks scandal

March 2, 2017
Medical Communications, Sales and Marketing Kickback, Novartis, south korea

South Korea’s Ministry of Food and Drug Safety has fined Novartis 200 million won ($174,936) over the payment of kickbacks …

News

Novartis’ Zykadia scores priority review and breakthrough designation from FDA

February 23, 2017
Sales and Marketing Novartis, zykadia

Novartis’ lung cancer treatment Zykadia (ceritinib) has been awarded both priority review and breakthrough therapy designation by the US Food …

News
novartis_appointment

New Managing Director of UK & Ireland for Novartis

February 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis

Novartis announced the appointment of Haseeb Ahmad as Managing Director for UK & Ireland. He joins from MSD, known as …

Appointment
donald_trump_september_3_2015

Trump meets with top pharma execs, reiterates pledge to lower “astronomical” prices

January 31, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Eli Lilly, Novartis, PhRMA, Trump

President Trump convened with a number of top pharma execs at the White House on Tuesday to discuss the key …

News
access_accelerated

22 pharma companies join forces for global non-communicable disease initiative

January 18, 2017
Research and Development BMS, Celgene, Eisai, Eli Lilly, GSK, J&J, JJ, MSD, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda

The World Economic Forum Annual Meeting in Switzerland has seen the launch of Access Accelerated, a global initiative consisting of …

News

NICE recommends Novartis’ previously CDF-exclusive kidney cancer treatment

January 13, 2017
Medical Communications, Sales and Marketing Afinitor, CDF, NICE, Novartis, everolimus

In a reappraisal decision by NICE, everolimus (Novartis’ Afinitor) has been recommended for the treatment of advanced renal cell carcinoma …

News
alessandro-riva

Gilead makes move in oncology by snaffling Riva from Novartis

January 4, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, Novartis, oncology

Gilead Sciences have made an ambitious move to boost its oncology business by appointing current head of global oncology development …

Appointment
novartis_window

Greek authorities raid Novartis’ offices after bribery allegations

January 4, 2017
Medical Communications, Research and Development Greece, Greek, Novartis, bribery

The investigation into practices by Novartis in its Greek operations has been accelerated after the attempted suicide of a Greek …

News
sun_pharma

Sun Pharma to acquire Novartis’s drug for $175 million

December 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Sun Pharma

Sun Pharma has announced that it will acquire Odomzo from Novartis for an upfront fee of $175 million alongside additional …

News
novartis_hq_day

Colombian government forces through near half-price cut of Novartis drug

December 21, 2016
Medical Communications, Sales and Marketing Colombia, Novartis

The Colombian government has lowered the price of Glivec (imatinib) by 44%, a cancer drug made by Novartis. The case …

News

Novartis seals two deals to bolster drug pipeline

December 21, 2016
Research and Development Conatus, Encore Vision, Novartis

Novartis has consolidated its ophthalmology position by acquiring Encore Vision, a Fort Worth-based US company. The company is focused on …

News
novartis_window

Novartis acquires Ziarco adding to dermatology pipeline

December 19, 2016
Sales and Marketing Novartis, Ziarco, eczema, oral

Novartis has announced that it will acquire UK-based Ziarco, to add Ziarco’s lead investigational oral treatment for moderate-to-severe eczema to …

News
basel_site

Phase 3 eye drug combo failure for Novartis

December 12, 2016
Research and Development, Sales and Marketing Novartis, ophthotech

Novartis’ has failed in its attempt to expand the applications of its anti-VEGF eye treatment Lucentis (ranibizumab) after the drug …

News
shutterstock_311949818

Neurodegenerative market to be worth $45 billion by 2022

December 12, 2016
Sales and Marketing Biogen, GBI Research, Novartis, Roche, Sanofi, neurodegenerative

Neurodegenerative disorders including Alzheimer’s, Parkinson’s, Huntington’s, amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) form a lucrative worldwide market which …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026